RecruitingNCT06523777

PRISM: Patient Experiences With PET Imaging in Prostate Cancer

Optimizing Prostate Cancer Care: Integrating Risks, Benefits and Patient Experiences in the New Era of Molecular Imaging

Sponsor

Yale University

Enrollment

350 participants

Start Date

Jul 25, 2024

Study Type

OBSERVATIONAL

Conditions

Prostate Cancer

Summary

The purpose of this study is to examine patient experiences, health-related quality of life, and decision-making associated with PET imaging for prostate cancer. In particular, Prostate Specific Membrane Antigen (PSMA) PET, a new and more sensitive form of imaging that can help identify metastatic cancer earlier and more reliably.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

Documented diagnosis of prostate cancer
Scheduled for their FIRST PSMA PET scan for prostate cancer
English-speaking
Willing and able to complete 4 surveys electronically or on paper at 3 timepoints (within 1 month after PET scan, 3-6 months, 12 months)
Able to use mobile device (smartphone or tablet) or computer with web access to complete study surveys or able to complete paper surveys

Exclusion Criteria3

Lack of access to a mobile device (smartphone or tablet) or computer with web access or unable to receive surveys by mail.
Unable to give consent and be enrolled
PET scan is being conducted within a clinical trial